State Street Corp Editas Medicine, Inc. Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Editas Medicine, Inc. stock. As of the latest transaction made, State Street Corp holds 4,590,913 shares of EDIT stock, worth $15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,590,913

Previous 8,760,151 47.59%

Holding current value

$15 Million

Previous $65 Million 67.02%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.67 - $7.28 $19.5 Million - $30.4 Million	-4,169,238 Reduced 47.59%	4,590,913 $21.4 Million
Q1 2024 May 15, 2024	BUY	$7.03 - $11.07 $25.9 Million - $40.9 Million	3,690,608 Added 72.8%	8,760,151 $65 Million
Q4 2023 Feb 14, 2024	SELL	$6.25 - $11.11 $4.38 Million - $7.79 Million	-701,399 Reduced 12.15%	5,069,543 $51.4 Million
Q3 2023 Nov 14, 2023	SELL	$6.92 - $9.31 $6.03 Million - $8.11 Million	-870,737 Reduced 13.11%	5,770,942 $45 Million
Q2 2023 Aug 14, 2023	SELL	$6.36 - $11.47 $9.68 Million - $17.5 Million	-1,522,512 Reduced 18.65%	6,641,679 $54.7 Million
Q1 2023 May 15, 2023	SELL	$7.03 - $11.53 $7.44 Million - $12.2 Million	-1,058,045 Reduced 11.47%	8,164,191 $59.2 Million
Q4 2022 Feb 14, 2023	BUY	$8.32 - $13.21 $23.9 Million - $38 Million	2,873,455 Added 45.26%	9,222,236 $81.8 Million
Q3 2022 Nov 15, 2022	SELL	$12.16 - $19.42 $18.6 Million - $29.7 Million	-1,531,109 Reduced 19.43%	6,348,781 $77.7 Million
Q2 2022 Aug 15, 2022	BUY	$9.99 - $21.35 $24 Million - $51.2 Million	2,399,852 Added 43.79%	7,879,890 $93.2 Million
Q1 2022 May 16, 2022	BUY	$14.08 - $27.63 $31.1 Million - $60.9 Million	2,205,431 Added 67.35%	5,480,038 $104 Million
Q4 2021 Feb 14, 2022	BUY	$26.55 - $40.57 $29.6 Million - $45.3 Million	1,116,589 Added 51.74%	3,274,607 $86.9 Million
Q3 2021 Nov 15, 2021	SELL	$39.27 - $72.94 $14.8 Million - $27.4 Million	-376,144 Reduced 14.84%	2,158,018 $88.7 Million
Q2 2021 Aug 16, 2021	BUY	$31.29 - $56.64 $6.58 Million - $11.9 Million	210,444 Added 9.06%	2,534,162 $144 Million
Q1 2021 May 17, 2021	BUY	$39.71 - $90.58 $2.32 Million - $5.29 Million	58,386 Added 2.58%	2,323,718 $97.6 Million
Q4 2020 Feb 16, 2021	SELL	$27.07 - $84.35 $17.4 Million - $54.3 Million	-643,231 Reduced 22.12%	2,265,332 $159 Million
Q3 2020 Nov 10, 2020	SELL	$28.06 - $37.16 $4.86 Million - $6.43 Million	-173,136 Reduced 5.62%	2,908,563 $81.6 Million
Q2 2020 Aug 14, 2020	BUY	$18.5 - $34.34 $19.5 Million - $36.2 Million	1,053,970 Added 51.98%	3,081,699 $91.2 Million
Q1 2020 May 11, 2020	BUY	$14.88 - $32.78 $30.2 Million - $66.5 Million	2,027,729 New	2,027,729 $40.2 Million

Others Institutions Holding EDIT

# of Institutions

252

Shares Held

58.7M

Call Options Held

494K

Put Options Held

417K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $225M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Editas Medicine, Inc. Transaction History